Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Peter Salovey is Director at Legend Biotech. OQRO lists 3 transactions filed with the SEC under this name, the latest on Nov 16, 2026, each linked to the official Form 4.
Director
Disclosures on record
3
Companies involved
1
As of the latest filing on , Peter Salovey reported holding 75,096 shares of Legend Biotech (LEGN), worth about $1.2M at the last close of $16 (Nov 16, 2026). In the last 12 months, Peter Salovey bought $183K in 2 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Legend Biotech LEGN | 75,096 | 75K direct | $16 | $1.2M | Nov 13, 2026 |
Is this Peter Salovey’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Legend BiotechLEGN
3 disclosures · Sep 2026 – Nov 2026 · 2 bought
Nov 12, 2026Bought~$94Kdisclosed Nov 16
DetailsOfficial recordNov 13, 2026Bought~$90Kdisclosed Nov 16
DetailsOfficial recordSep 24, 202628Kdisclosed Sep 29
DetailsOfficial recordOn the latest SEC Form 4, dated Nov 13, 2026, Peter Salovey reported holding 75,096 shares of Legend Biotech (LEGN). At the last close of $16 on Nov 16, 2026, that is about $1.2M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Peter Salovey reported 2 open-market purchases worth $183K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Peter Salovey bought shares on the open market in 2026.
In SEC filings since 2026: the latest open-market purchase is from 2026; no open-market sale is on record.
Legend Biotech (LEGN), from 2026 to 2026: 2 purchases and 0 sales.
Peter Salovey bought shares on the open market in 2026.
Peter Salovey reported 2 open-market purchases and 0 sales since 2026; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $183K2×2 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Peter Salovey reported 2 open-market purchases and 0 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.